ANP-302

N/A

Report date: 2024/12/03 16:41:11

NME

Base Information

Drug NameANP-302

Drug Alias NameANP 302ANP-302

ClassificationSmall molecules

Mechanisms of ActionCytotoxicity

TargetsUpdating

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAnp Technologies

China Registration ClassN/A

Develop Information

Active CompaniesAnp Technologies

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A